quarta-feira, agosto 31, 2005

Análise Pfizer

Más notícias no sector e na própria acção têm castigado a cotação levando-a a valores de 1998 e a PERs mínimos dos últimos 10 anos!

A retirado do mercado de seu medicamento Celabrex bem como o desafio dos medicamentos genéricos têm pressionado este negócio de excelentes rentabilidades e crescimentos de resultados.

Ficam os dados fundamentais aos quais adicionei uma avaliação do seu valor intrínseco recorrendo a uma calculadora da SmatMoney que podem encontrar em http://www.smartmoney.com/pricecheck/index.cfm (Basta digitar o código do título).









quarta-feira, agosto 10, 2005

Análise Anheuser-Busch

Maior cervejeira do mundo, dona de marcas líder como Budweiser. Um ano mais fraco nas vendas está a castigar a cotação. Estão a perder vendas para outras bebidas como o vinho. Fala-se dum efeito "SideWays", o filme de Alexander Payne nomeado para os óscares 2005 e que tem como pano de fundo o mundo dos vinhos.

Agora eu pergunto. Acham que este efeito conjuntural de curto-prazo vai ter algum efeito estrutural de longo-prazo no negócio de rentabilidades excelentes e com marcas muito fortes da Anheuser-Busch?

A empresa está a transaccionar com um PER de 17, o mais baixo dos últimos 9 anos!

A empresa tem um suporte relevante nos 44.5-45 que foi quebrado na apresentação de resultados do dia 27/07/2005. Já tenho uma boa posição no título da ordem dos $5.000. Abaixo dos 44.5 só reforço se for aos 41.5.

É verdade! O Warren Buffet anda a comprar disto. Anunciou-o em 21/04/2005.

Fica a análise fundamental, a técnica e os movimentos efectuados no título.







+ Dados Fundamentais em www.Reuters.com (NOTA: Vão ter é que se registar - gratuitamente - no site. Mas vão ver que vale a pena):

Profile - Descrição mais pormenorizada da empresa http://www.investor.reuters.com/CompanyOverview.aspx?ticker=BUD&target=%2fstocks%2fquickinfo%2fcompanyprofile%2foverview

Ratios - Comparação de Múltiplos / Taxas de Crescimento / Rentabilidades / Rácios de Dívida com Sector / Indústria / S&P
http://www.investor.reuters.com/MG.aspx?ticker=BUD.N&target=%2fstocks%2ffinancialinfo%2fratios%2fvaluation







PS: Nos últimos dias comprei um pouco ($1.000) de Pfizer e de Avon. Hoje vendi $1.000 de Lincare na resistência dos 43.5.

segunda-feira, agosto 01, 2005

Análise Harley-Davidson

Quem não conhece esta marca? Uma empresa de rentabilidades impressionantes e de crescimento de resultados galopantes. No dia do anúncio de resultados (13/04) dilvulgou uma redução da produção de motos para o ano e foi castigada por uns severos 18%/19%. Óptimo. Ficou a preços apetitosos relativamente ao seu valor intrínseco.

Esperei pelo momento técnico ideal que aconteceu numa ruptura com volume em alta de um triângulo ascendente. Como tem um gap por fechar ainda possui um grande caminho a percorrer.

Fica a análise fundamental, a técnica e os movimentos efectuados no título.











quinta-feira, julho 28, 2005

Análise Biomet

Uma excelente empresa com grandes perspectivas futuras afectada por questões técnicas de curto prazo e notícias negativas no que diz respeito a eventuais aliciamentos, já negados pela empresa, de médicos para subscrição dos seus produtos. Representa praticamente 10% da carteira e espero mantê-la e às suas rentabilidades por muito tempo.

Fica a análise fundamental, a técnica e os movimentos efectuados no título.















PS: Continuo a reforçar na Timberland (na zona de suporte dos 34) e vendi um pouco de AIG. Amanhã volto a publicar a carteira actualizada.

sábado, maio 21, 2005

Buffetology

O melhor livro sobre o método de investimento de Buffet elaborado com a colaboração de uma sua ex-nora.

Buffettology: The Previously Unexplained Techniques That Have Made Warren Buffett The Worlds

Americans are infatuated with the stock market. The number of households that own stock has increased from around 20 percent in the early 1980s to over 40 percent today. The market offers the hope of quick wealth and early retirement, and just about everyone who is in the market is looking for an edge, from sources such as CNBC and Wall Street Week to the Beardstown Ladies and "The Motley Fool." So it should be no surprise the most successful investor of our time--Warren Buffett--has been the subject of dozens of books and magazine articles. The value of Buffett's company, Berkshire Hathaway, has increased from $18 per share in 1965 to over $70,000 per share today. The interest in Buffett has spawned an approach to investing called "Buffettology," which is the subject of a book by the same name written by Buffett's former daughter-in-law, Mary Buffett.
In Buffettology, Mary Buffett, with the help of David Clark, details Warren Buffett's approach to investing. It's a style of investing based on the work of Benjamin Graham and one that requires a quality that most investors lack--discipline. Mary Buffett writes, "As you read through this book you will come to see that having a business perspective on investing is more about discipline than philosophy.... In short, other people's follies, brought on by fear and greed, will offer you, the investor, the opportunity to take advantage of their mistakes and benefit from the discipline of committing capital to investment only when it makes sense from a business perspective.... You will find that almost everything that relates to business perspective investing is alien to Wall Street folklore.

Buffettology examines Buffett's methods for valuing companies and selecting stocks--it even encourages you to buy a calculator and work through the valuation formulas that Buffett uses when researching companies to buy. The book not only serves as a useful guide to understanding how Buffett invests, it's an excellent primer to investing in stocks, whether you plan to become a Buffettologist or not. Highly recommended. --Harry C. Edwards, Business editor--This text refers to the Hardcover edition.

Review
Stevin Hoover Hoover Capital Management
Absolutely the best book ever written on Warren Buffett's investment methods.

Outros Livros:
The New Buffettology by Mary Buffet
The Warren Buffett Way, Second Edition by Robert G. Hagstrom
How to Think Like Benjamin Graham and Invest Like Warren Buffett by Lawrence A. Cunningham
The Warren Buffett Portfolio : Mastering the Power of the Focus Investment Strategy by Robert G. Hagstrom
The New Buffettology: How Warren Buffett Got and Stayed Rich in Markets Like This and How You Can Too! by David Clark
Trade Like Warren Buffett (Wiley Trading) by James Altucher

A minha análise fundamental!

Aprendi finanças na Faculdade de Economia do Porto. Balanço, Demonstrações de Resultados, Cash Flows, Múltiplos de Mercado, ...

No entanto, toda essa matéria dada em série aos alunos só começou a fazer sentido quando comecei a vasculhar em livros e artigos (muito mais práticos do que os manuais da Faculdade) sobre o método de investimento fundamental utilizado por Warren Buffet (este inspirado pelos ensinamentos de Benjamin Graham). Aí tudo se simplicou na minha cabeça. Descobri um guia, uma linha de pensamento que me organizou e instituiu um método.

Nos próximos posts vou falar sobre esses ensinamentos...

terça-feira, maio 17, 2005

Stock Market Lies

Stock Market Lies
By Richard Gibbons May 2, 2005

Value investors are independent thinkers. They don't need the crowd to validate their ideas, nor do they act contrarian simply for the sake of being different. While Sun Microsystems (Nasdaq: SUNW) and JDS Uniphase (Nasdaq: JDSU) were zooming up at the height of the tech bubble in the late 1990s, Warren Buffett was criticized as being out of touch with the realities of the new economy. Now that the bubble has popped, Buffett's company, Berkshire Hathaway, is close to all-time highs, while Sun and JDS Uniphase investors have been slaughtered.

Buffett wasn't avoiding technology just to be a contrarian. Berkshire's portfolio has piles of great businesses bought at reasonable prices, not just cheap businesses bought when nobody else wanted them. Companies like American Express (NYSE: AXP) and Moody's (NYSE: MCO) can hardly be considered cigar butts, but they've made Buffett wealthy nevertheless. Buffett's success can be attributed to well-reasoned purchases made within an investing framework based on value principles.

This approach sharply contrasts with most of the financial industry, which is why it is an interesting exercise to examine, from a value perspective, the disinformation that the financial industry pitches at investors every day.

"If you were out of the market for the best 30 days in the past decade, you would have lost money."
Mutual fund advisors often use this statistic to urge investors to stick with them for the long term, despite the fact that advisors themselves tend to be traders -- the typical managed mutual fund has an average turnover rate of 85%. But while being shocked and appalled at such hypocrisy is an entertaining hobby, it's also worthwhile to analyze the reasoning behind the claim.

The statistic is accurate: $10,000 invested in the S&P 500 a decade ago grew to almost $25,000 today (excluding dividends), while without the best 30 days, it would be worth only $7,700. But before making conclusions about market timing, consider the opposite statistic: If you were out of the market for the worst 30 days, you would have made $76,000. If the first statistic is saying that you should remain invested at all times, this statistic seems to be saying that trading to avoid bad days is critical. What gives?

Neither case is accurate. Rather, the statistic is used as propaganda to help fund companies pitch their funds and discourage investors from selling. There are many good reasons to be a long-term investor, including tax-free compounding, reduced expenses, and reduced risk. But this statistic is not a good reason.

What do these statistics mean to the individual investor? It's not clear, except that if you're a trader, some bad or good luck on a few select days could have very dramatic effects on your portfolio. But as a value investor, I think of some potential benefits of a margin of safety. By buying a stock at a discount to its intrinsic value, I'm likely to avoid the worst of the fallout on those worst 30 days, and my long-term performance should be superior.

"The trend is your friend."
This catchy one-liner reflects the momentum that stocks gather: Stocks going up tend to keep ascending, while stocks going down tend to keep falling. The logic driving the claim is a combination of psychology and faith. The psychology is that investors would prefer to buy a stock that's going up and therefore keep pushing it up. The faith is the belief that if something's going up, there must be some reason for it, so it will probably continue to do so.

This reasoning might work for day traders, but it is quite bizarre from a value perspective. First, if a stock is going up, then, all else being equal, it becomes less attractive to value investors because it is approaching -- or exceeding -- its intrinsic value. The upside is less and the downside is greater. Conversely, a stock going down becomes more attractive because both the margin of safety and potential return increase. Value investors love to buy goods when they're on sale. So the trend isn't a value investor's friend, but actually an enemy, like an evil maharaja, Jar Jar Binks, or a berserk koala.

The value investor's true friends are competitive advantages and a margin of safety. Competitive advantages ensure that the company will outperform others for a long time, while a margin of safety dramatically reduces the chance that the value investor will suffer significant losses.

"Run your profits, cut your losses."
This expression is the bedfellow of the "friendly trend" from above -- and with such a nickname, it has many bedfellows, including "buy high, sell higher" and "don't catch a falling knife." It means that if you're making money on an investment, don't sell quickly, but if you're losing money, then run for the hills. Frequently, it's implemented with some sort of stop-loss rule, such as "sell any stock that falls by 10%." The idea holds some appeal, since if you have the same number of winners and losers, but make more on the winners, then you will come out ahead.

However, this reasoning trips over the same stumbling block as momentum investing: It ignores valuation. If a stock has fallen 10% below your purchase price, that does not imply anything about the intrinsic value of the company. If the stock is down on negative news that decreases your estimate of intrinsic value, such as Merck (NYSE: MRK) after its Vioxx withdrawal, or Doral (NYSE: DRL) taking a hit to its balance sheet and changing its business model because of troubles with interest-only strips, then it makes sense to reevaluate the position.

But if the stock falls with no fundamental change, or falls further than is justified by the change in the intrinsic value, then a value investor would be more inclined to increase the position than decrease it. After all, the upside has become bigger and the downside smaller. The intrinsic value of Martha Stewart Living Omnimedia (NYSE: MSO) fell when Martha Stewart went to court, but the share price declined far more than the intrinsic value. Now that the homemaker's troubles seem to be behind her, shareholders who bought during the trial have tripled their investment.

"The market is always right."
Traders say this when the market is not doing what they expect it to do. It generally means that the trader believes his or her reasoning to be incorrect, since the market isn't acting as planned. Consequently, the traders should cut their losses. I love this expression because it's so pessimistic. It reminds me of Eeyore, blue-grey donkey and portfolio manager: "I was just kind of guessing where the stock was going anyway, and I was wrong. Oh, well."

Value investors think this expression is quaint. The market is right occasionally, but overall it tends to be pretty bipolar, with individual stocks priced both above and below intrinsic value. Really, if a stock is priced at less than the discounted value of its expected future returns, then the market is wrong. In such cases, value investors are able to make extraordinary profits both from long-term growth in the business and from the stock returning to intrinsic value. In fact, identifying such stocks is Motley Fool Inside Value's primary goal.

In conclusion
Many common investing expressions don't hold up when examined from a value perspective. However, this can be a great thing, as those who do believe in such maxims may push stocks away from intrinsic values, providing an opportunity for value investors to profit.